Targeting acid/base transporters in cancer cells via CAIX might even be advantageous over direct inhibition of the acid/base transporters, since these proteins are usually expressed in a variety of healthy tissue, rendering cancer cell-specific targeting difficult. The gene discussed is CA9; the disease is cancer.